Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Fibrobiologics Inc increased its cash reserves by 304.37%, or 6.90m. Cash Flow from Financing totalled 13.79m or -- of revenues. In addition the company used 6.40m for operations while cash used for investing totalled 495.00k.
Cash flow per share | -0.6924 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.073 |
---|---|
Tangible book value per share | -0.073 |
More ▼
Balance sheet in USDView more
Current ratio | 0.6424 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼